Skip to content

Drug interactions

Montelukast + Tecovirimat

Severity: Minor

Montelukast and Tecovirimat: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tecovirimat is a weak CYP3A4 inducer and may slightly reduce montelukast concentrations. Tecovirimat courses are short, so any effect on montelukast efficacy is expected to be minimal.

What this interaction means in plain words

Montelukast and Tecovirimat have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Montelukast belongs to Respiratory; Tecovirimat belongs to Miscellaneous.

Evidence level: Low

Why it happens

Tecovirimat weakly induces CYP3A4, modestly increasing montelukast clearance.

What to do

No dose adjustment is needed; monitor respiratory symptom control during the tecovirimat course.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Montelukast and Tecovirimat, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Montelukast with Tecovirimat?

MediHelp rates the interaction as minor. Montelukast and Tecovirimat have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Tecovirimat is a weak CYP3A4 inducer and may slightly reduce montelukast concentrations. Tecovirimat courses are short, so any effect on montelukast efficacy is expected to be minimal.

How serious is the interaction between Montelukast and Tecovirimat?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose adjustment is needed; monitor respiratory symptom control during the tecovirimat course.

What other medicines interact with Montelukast?

MediHelp also lists interactions of Montelukast with, for example, Apalutamide, Carbamazepine, Deferasirox. The full list is on the Montelukast page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in